1. Home
  2. BDTX vs UIS Comparison

BDTX vs UIS Comparison

Compare BDTX & UIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BDTX
  • UIS
  • Stock Information
  • Founded
  • BDTX 2014
  • UIS 1942
  • Country
  • BDTX United States
  • UIS United States
  • Employees
  • BDTX N/A
  • UIS N/A
  • Industry
  • BDTX Biotechnology: Biological Products (No Diagnostic Substances)
  • UIS EDP Services
  • Sector
  • BDTX Health Care
  • UIS Technology
  • Exchange
  • BDTX Nasdaq
  • UIS Nasdaq
  • Market Cap
  • BDTX 132.5M
  • UIS 271.5M
  • IPO Year
  • BDTX 2020
  • UIS N/A
  • Fundamental
  • Price
  • BDTX $2.48
  • UIS $4.54
  • Analyst Decision
  • BDTX Strong Buy
  • UIS Hold
  • Analyst Count
  • BDTX 6
  • UIS 1
  • Target Price
  • BDTX $14.83
  • UIS $6.50
  • AVG Volume (30 Days)
  • BDTX 1.4M
  • UIS 714.4K
  • Earning Date
  • BDTX 08-05-2025
  • UIS 08-04-2025
  • Dividend Yield
  • BDTX N/A
  • UIS N/A
  • EPS Growth
  • BDTX N/A
  • UIS N/A
  • EPS
  • BDTX 0.09
  • UIS N/A
  • Revenue
  • BDTX $70,000,000.00
  • UIS $1,952,700,000.00
  • Revenue This Year
  • BDTX N/A
  • UIS N/A
  • Revenue Next Year
  • BDTX N/A
  • UIS $3.79
  • P/E Ratio
  • BDTX $28.38
  • UIS N/A
  • Revenue Growth
  • BDTX N/A
  • UIS N/A
  • 52 Week Low
  • BDTX $1.20
  • UIS $3.32
  • 52 Week High
  • BDTX $6.75
  • UIS $8.93
  • Technical
  • Relative Strength Index (RSI)
  • BDTX 57.54
  • UIS 49.68
  • Support Level
  • BDTX $2.34
  • UIS $4.37
  • Resistance Level
  • BDTX $2.71
  • UIS $4.72
  • Average True Range (ATR)
  • BDTX 0.17
  • UIS 0.22
  • MACD
  • BDTX -0.02
  • UIS 0.01
  • Stochastic Oscillator
  • BDTX 58.93
  • UIS 51.40

About BDTX Black Diamond Therapeutics Inc.

Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.

About UIS Unisys Corporation New

Unisys Corp is engaged in the provision of technology solutions for clients across the government, financial services, and commercial markets. It operates through three business segments: Digital Workplace Solutions (DWS),Cloud, Applications & Infrastructure Solutions (CA&I), and Enterprise Computing Solutions (ECS). DWS provides workplace solutions featuring intelligent workplace services, proactive experience management and collaboration tools to support business growth. CA&I which provides digital transformation in the areas of cloud migration and management. ECS which provides solutions that harness secure, high-intensity enterprise computing and enable digital services through software-defined operating environments. Majority of revenue is from ECS segment.

Share on Social Networks: